SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $345,377,333 |
| Positions | 7 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SIONNA THERAPEUTICS INC | SION | COM | $109,008,540 | 2,478,030 |
| ZENAS BIOPHARMA INC | ZBIO | COM | $99,468,255 | 3,919,159 |
| IMMUNOME INC | IMNM | COM | $76,576,401 | 3,613,799 |
| BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | COM NEW | $20,017,329 | 2,626,946 |
| COMPASS THERAPEUTICS INC | CMPX | COM | $17,056,049 | 7,788,150 |
| UPSTREAM BIO INC | UPB | COM | $17,021,145 | 2,459,703 |
| CAMP4 THERAPEUTICS CORP | CAMP | COM | $6,229,614 | 1,425,541 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.